Assessment of Safety , Clinical Efficacy with QLETLI in Non-infectious Uveitis (UV)

Summary

This is a multicenter, prospective, post-marketing clinical study with a total of 60 uveitis (UV) subjects planned to be enrolled. Screening period (-2\~0 weeks) ,Treatment period (1-22 weeks), Follow-up period, At the same time, plasma concentration will be determined

Timeline

Start

2021-12-27

Primary completion

2024-12-30

Completion

2024-12-30

Drugs

Indications